beta-Lactamase Inhibitors
Showing 1 - 25 of 7,902
Sepsis, Septic Shock Trial (Piperacillin/tazobactam or temocillin, Meropenem)
Not yet recruiting
- Sepsis
- Septic Shock
- Piperacillin/tazobactam or temocillin
- Meropenem
- (no location specified)
Oct 3, 2022
Extended Spectrum Beta Lactamase Producing Organisms In Urinary
Not yet recruiting
- Urinary Tract Infections
- (no location specified)
Nov 18, 2021
Advancing Age and Mortality at 30 Days in Bacteremia E. Coli
Completed
- Beta-lactamase Extended Spectrum, E. Coli, Elderly, Mortality, Risk Factor
-
Nantes, FranceCHU Nantes
Sep 20, 2021
Developing Microbials to Fight Extended-spectrum
Active, not recruiting
- Extended Spectrum Beta Lactamases (ESBL) E. Coli
- examination of stool sample
- +2 more
-
Basel, SwitzerlandUniversity Hospital Basel, Division of Clinical Microbiology
Aug 3, 2021
Heart Failure, Type 2 Diabetes Trial in San Antonio (Beta-hydroxy-butyrate)
Active, not recruiting
- Heart Failure
- Type 2 Diabetes Mellitus
-
San Antonio, Texas
- +1 more
Jan 10, 2022
Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, Pseudomonas Aeruginosa Trial in Philadelphia (PMT)
Not yet recruiting
- Multidrug Resistant Bacterial Infection
- +4 more
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Nov 17, 2022
AML, Acute Myeloid Leukemia Trial in Charlottesville (Cardioprotection)
Recruiting
- AML
- Acute Myeloid Leukemia
-
Charlottesville, VirginiaUniversity of Virginia
Jul 2, 2022
Angiotensin Converting Enzyme Inhibitors and Angiotensin
Not yet recruiting
- COVID-19 Pneumonia
- Covid_19
- (no location specified)
Jun 5, 2022
Immune Checkpoint Inhibitors Nephrotoxicity
Recruiting
- Kidney Injury
- Antineoplastics Toxicity
- Early kidney damage biomarkers
- Predisposition to kidney injury biomarkers
-
Salamanca, Spain
- +1 more
Jul 26, 2022
Susceptibility of Enterobacteriaceae and Pseudomonas Aeruginosa
Active, not recruiting
- Antibiotic Resistant Strain
-
Paris, Ile-de-France, FranceGroupe Hospitalier Paris Saint Joseph
Mar 30, 2022
Breast Cancer, Cardiotoxicity Trial in Florence (Bisoprolol, Ramipril, Placebo)
Active, not recruiting
- Breast Cancer
- Cardiotoxicity
- Bisoprolol
- +2 more
-
Florence, ItalyAzienda Ospedaliero-Universitaria Careggi, Florence University
Jan 16, 2022
Research of Consequences on Digestive Tract Following Proposed
Recruiting
- Urinary Tract Infections
- Urinary Tract Infections in Children
- Amikacin
- usual antibiotic treatment
-
Clamart, Ile-de France, France
- +19 more
Jan 25, 2023
Heart Failure Trial in Tel Aviv (ACE inhibitors, beta blockers)
Recruiting
- Heart Failure
- ACE inhibitors
- beta blockers
-
Tel Aviv, IsraelTel Aviv Medical Center
Feb 1, 2022
Bacterial Infections Trial in Adelaide (QPX2015, Placebo oral capsule)
Completed
- Bacterial Infections
- QPX2015
- Placebo oral capsule
-
Adelaide, South Australia, AustraliaCMAX
Oct 6, 2022
Diabetes, Cardiovascular Diseases Trial in Singapore (Renin-angiotensin-aldosterone system inhibitors, Beta blocker, SGLT2
Recruiting
- Diabetes Mellitus
- Cardiovascular Diseases
- Renin-angiotensin-aldosterone system inhibitors
- +2 more
-
Singapore, SingaporeSingapore General Hospital (SGH)
Apr 28, 2021
Urinary Tract Infections Trial in France (Temocillin, meropenem or imipenem)
Completed
- Urinary Tract Infections
- Temocillin
- meropenem or imipenem
-
Fort-de-france, Martinique, France
- +15 more
Apr 16, 2021
Neonatal Sepsis Trial in Babati (Labinic (R) probiotic mixture, Placebo)
Not yet recruiting
- Neonatal Sepsis
- Labinic (R) probiotic mixture
- Placebo
-
Babati, Manyara, TanzaniaHaydom Lutheran Hospital
Nov 23, 2020
Enterobacteriaceae Infections Trial in Bayonne, Bordeaux (Piperacillin-tazobactam)
Not yet recruiting
- Enterobacteriaceae Infections
-
Bayonne, France
- +1 more
Jun 4, 2021
Beta Lactam Resistant Bacterial Infection, Enterobacteriaceae Infections, Bacteremia Trial in Canada, Israel
Recruiting
- Beta Lactam Resistant Bacterial Infection
- +2 more
-
Montreal, Quebec, Canada
- +7 more
Jul 25, 2022
STEMI - ST Elevation Myocardial Infarction, Left Ventricular Systolic Dysfunction Trial (Dapagliflozin 10Mg Tab, Placebo)
Not yet recruiting
- STEMI - ST Elevation Myocardial Infarction
- Left Ventricular Systolic Dysfunction
- Dapagliflozin 10Mg Tab
- Placebo
- (no location specified)
Sep 6, 2021
Beta Lactam Resistant Bacterial Infection, Enterobacteriaceae Infections, Bacteremia Trial in Israel (Piperacillin / Tazobactam
Recruiting
- Beta Lactam Resistant Bacterial Infection
- +2 more
- Piperacillin / Tazobactam Injection
- Meropenem
-
Haifa, Israel
- +3 more
Jul 25, 2022
Bloodstream Infections Trial in Australia, Singapore (Meropenem, Piperacillin-tazobactam combination product)
Active, not recruiting
- Bloodstream Infections
- Meropenem
- Piperacillin-tazobactam combination product
-
New Lambton, New South Wales, Australia
- +5 more
Nov 3, 2020